Acute Myocardial Infarction Study of Adenosine II - AMISTAD II

Description:

A placebo controlled, phase III trial to compare the incidence of death and CHF in acute myocardial infarction patients treated with one of two doses of adenosine or placbo as an adjunct to thrombolysis or angioplasty.